SCHEMBL7701674

SCHEMBL7701674

O=C(Nc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1)c1cccc([N+](=O)[O-])c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.55
KMT2A Q03164 8/20 0.55
CHEK1 O14757 2/20 0.50
THRA P10827 1/20 0.49
KDR P35968 1/20 0.49
NPC1 O15118 4/20 0.48
RAB9A P51151 4/20 0.48
CASP3 P42574 2/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
PKM P14618 1/20 0.48
MAPT P10636 5/20 0.48
ALDH1A1 P00352 3/20 0.48
LMNA P02545 2/20 0.47
HPGD P15428 1/20 0.47
ATM Q13315 1/20 0.47
CDK1 P06493 1/20 0.47
CDK2 P24941 1/20 0.47
KDM4E B2RXH2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7090902 0.90 MEN1 (0.51) MEN1KMT2ACHEK1THRAKDR
SCHEMBL7703594 0.90 CHEK1 (0.53) MEN1KMT2ACHEK1KDRNPC1
SCHEMBL6999716 0.90 CHEK1 (0.53) MEN1KMT2ACHEK1KDRNPC1
SCHEMBL7094928 0.85 KDR (0.64) MEN1KMT2ACHEK1KDRNPC1
SCHEMBL7093397 0.85 CHEK1 (0.54) MEN1KMT2ACHEK1KDRNPC1
Water SCHEMBL7089950 0.84 KDR (0.63) MEN1KMT2ACHEK1KDRNPC1
SCHEMBL6994408 0.81 KDR (0.64) CHEK1KDRNPC1CDK1CDK2
SCHEMBL7698430 0.81 KDR (0.64) CHEK1KDRMAPTLMNAHPGD
SCHEMBL7091231 0.81 CHEK1 (0.56) CHEK1KDRCDK1CDK2
SCHEMBL7167280 0.81 MEN1 (0.48) MEN1KMT2ACHEK1KDRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed